Promoter holding
64.27%
TL
Taurus Life Sciences Limited - Due diligence report
A 360° intelligence report on Taurus Life Sciences Limited: trust score, financial health, credit view, compliance, directors, growth and di…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Taurus Life Sciences Limited — 360° Intelligence Report
Generated from MCA filings & public records70/100
Trust Score
Moderate
Taurus Life Sciences Limited is assessed as Moderate with a Trust Score of 70/100. Taurus Life Sciences Limited is an active public limited indian non-government company incorporated in 2010, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 23 Aug 2026 from the latest processed filings. Taurus Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
85/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
Charges position: 2 open (5.60 cr) · 6 satisfied (6.36 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 5 | 48.0 cr |
| Central Bank Of India | 2 | 48.0 cr |
| Gujarat State Financial Corporation | 1 | 48.0 cr |
Compliance Score: 85/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (3 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HARISHBHAI KESHAVBHAI LATHIYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MITABEN HARISHBHAI LATHIYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VAIDIK MANSHUKHBHAI PARSANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Taurus Parentrals Private Limited | Associate Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 16+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 3.45 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 5.60 cr already registered.
- Compliance record supports lending.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
04 Aug 2025
Charge created
Others - 1.50 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
VAIDIK MANSHUKHBHAI PARSANA
24 Jul 2024
Charge satisfied
Others
23 Feb 2024
Director appointed
VAIDIK MANSHUKHBHAI PARSANA (Director)
02 Jun 2022
Charge created
Others - 4.10 cr
10 May 2022
Charge satisfied
Others
11 Oct 2021
Director appointed
HARISHBHAI KESHAVBHAI LATHIYA (Director)
05 Jul 2021
Director ceased
HARISHBHAI KESHAVBHAI LATHIYA
04 Feb 2021
Securities allotted
104503 Equity Shares - 24.04 Lakh raised
09 Jul 2020
Charge created
Others - 37.00 Lakh
22 Oct 2019
Charge created
Others - 2.88 cr
10 Nov 2014
Charge satisfied
Central Bank Of India
30 Sep 2014
Director ceased
HARSH HARISHBHAI LATHIYA
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Glr Innovations Limited | U24230DL2021PLC390105 | Delhi, Delhi, India |
| Trio Remedies Pvt Ltd | U24231GJ1989PTC012865 | Ahmedabad, Gujarat, India |
| Fine Aromatics And Herbal Extracts Private Limited | U01117MH2004PTC148792 | Mumbai, Maharashtra, India |
| Seraga Lifesciences Private Limited | U15133GJ2018PTC101650 | Ahmedabad, Gujarat, India |
| Advanced Biotech Products Private Limited | U24231TN1993PTC025424 | Chennai, Tamil Nadu, India |
| Arconikh International Private Limited | U29309PN2020PTC191227 | Pune, Maharashtra, India |
| Mediclove Biotech Private Limited | U24239HR2019PTC081221 | Panchkula, Haryana, India |
| Matteo Formulation Private Limited | U24290UR2022PTC014678 | Roorkee, Uttarakhand, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Taurus Life Sciences Limited before audits and certifications: compliance score 85/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Taurus Life Sciences Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Taurus Life Sciences Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Taurus Life Sciences Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Taurus Life Sciences Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Taurus Life Sciences Limited an active company?
Taurus Life Sciences Limited has MCA status “Active” with a compliance score of 85/100 (Low Risk).
Is Taurus Life Sciences Limited financially healthy?
Taurus Life Sciences Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Taurus Life Sciences Limited?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Taurus Life Sciences Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Taurus Life Sciences Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.
Is Taurus Life Sciences Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 85/100 (Low Risk).
Is it risky to lend to Taurus Life Sciences Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
